Paper895764
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.
Veronesi U and 19 others. N Engl J Med, 1977. Cited by 571 papers, by iCite.
Cite this record
ConductScience Library. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. Papers, record 895764. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/895764
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extremities | Major topic |
| Lymph Node Excision | Major topic |
| Melanoma | Major topic |
| Skin Neoplasms | Major topic |
| Aged | |
| Evaluation Studies as Topic | |
| Female | |
| Humans | |
| Lymphatic Metastasis | |
| Male | |
| Prognosis | |
| Prospective Studies | |
| Sex Factors | |
| World Health Organization |
Source PubMed
Cited by82
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 571 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42104033 | Perspective Editorial: Assessment of Survival Benefit from Sentinel Node Biopsy for Melanoma: A Systematic Review and Meta-analysis. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/42104033 | PubMed |
| 40883533 | Melanoma Great Debate: Targeted Versus Complete Nodal Dissection Following Neoadjuvant Therapy for Melanoma: Is it Time to Push Forward or Hold Off on Continued De-Escalation of Surgery? | Ann Surg Oncol | 2025 | https://conductscience.org/library/papers/40883533 | PubMed |
| 40717884 | Validity of Intraoperative Imprint Cytology and Frozen Section for Sentinel Lymph Node Assessment in Breast Cancer: A Single-Centre Experience. | Cureus | 2025 | https://conductscience.org/library/papers/40717884 | PubMed |
| 40338298 | [Value of surgery for malignant melanoma in the context of current adjuvant and neoadjuvant treatment concepts]. | Dermatologie (Heidelb) | 2025 | https://conductscience.org/library/papers/40338298 | PubMed |
| 39550033 | Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. | Ann Oncol | 2025 | https://conductscience.org/library/papers/39550033 | PubMed |
| 38842606 | Management of Localized Melanoma in the Anti-PD-1 Era. | Curr Oncol Rep | 2024 | https://conductscience.org/library/papers/38842606 | PubMed |
| 35033317 | Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies. | Curr Probl Surg | 2022 | https://conductscience.org/library/papers/35033317 | PubMed |
| 31857858 | Evolving management of positive regional lymph nodes in melanoma: Past, present and future directions. | Oncol Rev | 2019 | https://conductscience.org/library/papers/31857858 | PubMed |
| 30548543 | Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers. | J Surg Oncol | 2019 | https://conductscience.org/library/papers/30548543 | PubMed |
| 30481384 | Current management of regional lymph nodes in patients with melanoma. | J Surg Oncol | 2019 | https://conductscience.org/library/papers/30481384 | PubMed |
| 30232648 | Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma. | Curr Treat Options Oncol | 2018 | https://conductscience.org/library/papers/30232648 | PubMed |
| 30190874 | Lymph nodes and the melanoma surgeon: re-defining a long-term relationship. | Melanoma Manag | 2016 | https://conductscience.org/library/papers/30190874 | PubMed |
| 29777421 | Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials. | Clin Exp Metastasis | 2018 | https://conductscience.org/library/papers/29777421 | PubMed |
| 29492467 | Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma. | Laryngoscope Investig Otolaryngol | 2018 | https://conductscience.org/library/papers/29492467 | PubMed |
| 28690674 | The Veronesi quadrantectomy: an historical overview. | Ecancermedicalscience | 2017 | https://conductscience.org/library/papers/28690674 | PubMed |
| 27051803 | Combined dabrafenib and trametinib therapy in metastatic melanoma and organ transplantation: Case report and review of the literature. | JAAD Case Rep | 2015 | https://conductscience.org/library/papers/27051803 | PubMed |
| 26790922 | Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial. | Lancet Oncol | 2016 | https://conductscience.org/library/papers/26790922 | PubMed |
| 26663853 | Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2016 | https://conductscience.org/library/papers/26663853 | PubMed |
| 26098776 | Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation. | Oncotarget | 2015 | https://conductscience.org/library/papers/26098776 | PubMed |
| 25311346 | MSLT-I-response of clinical trial investigators. | Nat Rev Clin Oncol | 2014 | https://conductscience.org/library/papers/25311346 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/895764
GET https://conductscience.org/api/papers/v1/895764/cited_by?page=2